Published on December 10, 2016

New Developments in the Medtronic Infuse Litigation

St. Louis court clears way for first Infuse jury trial

A St. Louis judge has cleared the way for the first jury trial involving personal injuries allegedly caused by Medtronic’s Infuse Bone Graft.

The injury claims of plaintiff Trisha Keim are set for trial in February, after Judge Mark H. Neill of …

Original article here

Patients who received Medtronic’s Infuse product to get $8.45 million in settlements patients who were injured by Medtronic’s controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor with financial ties to the company used the product …

Click here for the original post

In letter to Franken, FDA defends handling of Medtronic’s Infuse study

After receiving the FDA’s response to his questions, Franken says the handling of Medtronic’s Infuse study signals a broader need to change how the agency safeguards the public’s health.

He called for “a more robust, proactive medical device …

Original article here

FDA hearing on off-labels use of devices explores risks to patients

First, health policy expert Diana Zuckerman displayed huge photos of the disfigured, bruised faces of two babies who had been implanted with Medtronic’s Infuse Bone Graft product in their skulls.

Then Zuckerman, who is president of the National Center …

See the original post

Ohio judge dismisses hundreds of off-label Medtronic Infuse patient lawsuits district court judge, Timothy S Black (Southern Ohio, USA) has dismissed the accusation of several hundred plaintiffs that they have been treated off-label with Medtronic’s Infuse.

The plaintiffs were all former patients of Atiq Durrani …

The original story is here

Medtronic Disentangles Itself From Durrani Infuse Lawsuits patients in Ohio who had back surgery performed by federal fugitive, Atiq Durrani M.D., joined together to sue Medtronic because Durrani used Infuse in an alleged off-label fashion.

Durrani is currently practicing back surgery on Pakistanis after …

Full article

Court Denies All Medtronic Summary Requests in Infuse Litigation

Parker Waichman LLP notes a significant loss for medical device manufacturer, Medtronic, Inc.

Judge Mark H. Neill of St. Louis’ 22nd Judicial Circuit has ruled that the company’s Infuse medical device may have been …

Read the original article here

Medtronic headaches resurface as patients awarded $8.45 Million past month marks a pivotal decision in the ongoing litigation over the Medtronic bone graft product, Infuse, as two patients injured by Medtronic’s product will receive a combined $8.45 million in settlements—not from the manufacturers of the …

Read the original article here

A look behind the Star Tribune’s special report on Medtronic, ‘A Question of Risk’ Sunday before last, the Star Tribune published a front-page story laying out how Medtronic, one the area’s highest profile corporations, “misfiled” a report on adverse reactions to the company’s lucrative but problematic bone fusion device, Infuse.

Read the full story here

Sen. Franken pushes for review of Medtronic Infuse study – Mass Device InFuse Senator Al Franken (D-Minn.) is pushing for more details on Medtronic’s (NYSE:MDT) study of its Infuse Bone Graft, saying that the product may have “potentially skewed the risk profile” for patients and exposed “insufficient vigilance …

The full original post can be seen here

Leave a Comment

Your email address will not be published. Required fields are marked *